LysoPC(20:4)
Based on 1 Customer Validation
LysoPC 20:4 (20:4) (1-Arachidonoyl-sn-glycero-3-phosphocholine) is a serum metabolite. LysoPC 20:4 (20:4) decreases in tumor-bearing mice, but the reduction is not significant. LysoPC (20:4) can be used in cancer and obesity-related research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 96.74%
- CAS. Nr.: 60701-99-7
- Formel: C28H50NO7P
- Molecular Weight:543.67
-
Speicherung:Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
Human Endogenous Metabolite |
LysoPC 20:4 (20:4) (1-Arachidonoyl-sn-glycero-3-phosphocholine) is a serum metabolite. LysoPC 20:4 (20:4) decreases in tumor-bearing mice, but the reduction is not significant. LysoPC (20:4) can be used in cancer and obesity-related research[1][2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 60701-99-7
-
Appearance Oil
-
Molecular Weight 543.67
-
Formel C28H50NO7P
-
Color White to yellow
-
SMILES
C[N+](C)(C)CCOP(OC[C@H](O)COC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)([O-])=O
-
Synonyms
1-Arachidonoyl-sn-glycero-3-phosphocholine
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Lösungsmittel & Löslichkeit
DMSO : 50 mg/mL (91.97 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Reinheit & Dokumentation
-
Data Sheet (265 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Raynor A, et al. Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases. Lipids Health Dis. 2015;14:69. Published 2015 Jul 11. [Content Brief]
[2]. Bi Y, et al. Effects of Hawthorn Flavonoids on Intestinal Microbial Community and Metabolic Phenotype in Obese Rats. Adv Biol (Weinh). 2024;8(10):e2300514. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.8394 mL | 9.1968 mL | 18.3935 mL | 45.9838 mL |
| 5 mM | 0.3679 mL | 1.8394 mL | 3.6787 mL | 9.1968 mL | |
| 10 mM | 0.1839 mL | 0.9197 mL | 1.8394 mL | 4.5984 mL | |
| 15 mM | 0.1226 mL | 0.6131 mL | 1.2262 mL | 3.0656 mL | |
| 20 mM | 0.0920 mL | 0.4598 mL | 0.9197 mL | 2.2992 mL | |
| 25 mM | 0.0736 mL | 0.3679 mL | 0.7357 mL | 1.8394 mL | |
| 30 mM | 0.0613 mL | 0.3066 mL | 0.6131 mL | 1.5328 mL | |
| 40 mM | 0.0460 mL | 0.2299 mL | 0.4598 mL | 1.1496 mL | |
| 50 mM | 0.0368 mL | 0.1839 mL | 0.3679 mL | 0.9197 mL | |
| 60 mM | 0.0307 mL | 0.1533 mL | 0.3066 mL | 0.7664 mL | |
| 80 mM | 0.0230 mL | 0.1150 mL | 0.2299 mL | 0.5748 mL |
LysoPC(20:4) Related Classifications
HY-177475 Related Classifications
Powered by Bioz
- LysoPC(20:4)
- 60701-99-7
- 1-Arachidonoyl-sn-glycero-3-phosphocholine
- Endogenous Metabolite
- Prevotellaceae_UCG-001
- polyunsaturated lysophosphatidylcholine
- obesity
- high-fat diet-induced obese rats
- hawthorn flavonoid
- Clostridia_UCG-014
- serum metabolite
- tumour-bearing mice
- B16.F10-induced melanoma lung metastases
- rat intestinal flora
- Inhibitor
- inhibitor
- inhibit